Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Cosmetic surgery includes surgical and nonsurgical procedures that enhance and reshape structures of the body to improve appearance and confidence. Improving aesthetic appeal, symmetry, and proportion are the key goals of the cosmetic surgeries. The demand for minimally invasive procedures, such as botulinum toxin and facial filler injections, has increased dramatically over the past decade. Furthermore, according to American society of plastic surgeons, in 2017, USD 16.7 billion was spent on cosmetic procedures in the U.S. Likewise, 1.8 million procedures were surgical and 15.7 million were minimally-invasive procedures. Additionally, growing demand for non-invasive techniques has also led to enormous growth in the cosmetics surgical and non-surgical procedures market.
The cosmetics surgical and non-surgical procedures market has gained significant growth due to remarkable increase in popularity for non-invasive and minimally invasive aesthetic procedures. These techniques reduces the prevalence of post-surgical complications, boost speedy recovery and also reduce issues related to pain and scarring. Moreover, changing lifestyle, increasing affordability and advancements in technologies are some of the major factors contributing to the growth of this market. However, stringent regulatory policies across North America and Europe are hampering the growth of cosmetics surgical and non-surgical procedures market.
The cosmetics surgical and non-surgical procedures market is segmented by gender, age group, procedure, end user and geography
On the basis of gender, the cosmetics surgical and non-surgical procedures market is segmented into male and female. Over the past few years, there has been an increased demand from men requesting plastic surgery. Men of all ages are requesting plastic surgery for a more balanced nose, a rejuvenated face and a trimmer waistline.
Based on age group, the cosmetics surgical and non-surgical procedures market is classified into 13-19 year, 20-29 year, 30-39 year, 40-54 year and 55 & over. Some of the most common procedures for teens include nose reshaping, male breast reduction, ear surgery, laser hair removal and laser skin resurfacing.
Various procedures were studied in this market such as surgical procedures and nonsurgical procedure. The surgical procedures segment is further classified into breast augmentation, liposuction, nose reshaping, eyelid surgery and tummy tuck. Furthermore, the nonsurgical procedure segment is categorized into botulinum toxin, soft tissue fillers, chemical peel and laser hair removal. The nonsurgical cosmetic procedure segment is likely to witness the fastest growth in coming years due to high awareness and lower risk in comparison to surgical procedures. Moreover, nonsurgical procedures are more economical and a large number of relevant service providers are easily available.
Based on end-user, the cosmetics surgical and non-surgical procedures market is segmented into private surgery centres/clinics, hospitals, medical spa and others. Currently, the private surgery centres/clinics segment has significant share in the cosmetics surgical and non-surgical procedures market and is also estimated to dominate the market during the forecast period. Increasing number of clinics, modified services & customer service fulfilment and combination treatments are key factors boosting the private surgery centres/clinics segment.
By geography, the cosmetics surgical and non-surgical procedures market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America accounted for the largest market share in 2018, followed by Asia-Pacific. Factors such as rise in the importance of aesthetic looks, technology advancements and availability of cosmetics & dermatology specialists are propelling the market growth in North America. Moreover, the Asia-Pacific region is projected to grow at a fastest CAGR during the forecast period, due to advancement in health care services, high disposable income and increasing awareness of aesthetics procedures.
Some of the major players operating in the global cosmetics surgical and non-surgical procedures market includes Allergan plc, Merz Pharma GmbH & Co. KGaA, Cutera, Cynosure, Inc., Ipsen, Sientra, Inc., Alma Lasers, Johnson & Johnson., Syneron, Valeant Pharmaceuticals International, Inc., Mentor Worldwide Llc., Sinclair IS Pharma and Lumenis. Market players are involved in new product launches and acquisitions to exploit maximum revenue potential in global cosmetics surgical and non-surgical procedures market.
i. September 2018, Allergan PLC launched new SkinMedica LUMIVIVE System, an innovative skincare product. LUMIVIVE offers full atmospheric protection and fights the signs of aging for optimal skin health and vitality
ii. August 2018: Alma Lasers Ltd. announced the launch of PICO CLEAR, which holds the promise of optimal results for various challenging dermatological indications in fewer treatments. The state-of-the-art PICO CLEAR technology offers a wide range of dermatology applications, including the removal of dark ink tattoos, colored ink tattoos, lentigines, café-au-lait birthmarks, benign pigmented lesions, acne scars and wrinkles
iii. December 2017: Allergan plc, and Paratek Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) to review Seysara (sarecycline) for the treatment of moderate to severe acne vulgaris in patients 9 years of age and older
iv. July 2016: Galderma Pharma S.A. announced that Japan’s Ministry of Health, Labor and Welfare has approved Epiduo, a novel topical treatment for acne vulgaris in Japan. Since its first marketing authorization in 2007, Epiduo Gel has now been approved in over 60 countries around the world for the treatment of acne vulgaris, and is the most prescribed topical acne medication in the world
Why to buy this report:
